Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. (Q43416448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Giuseppe Salemi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Damiano Paolicelli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Vincenzo Brescia Morra

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Bruno Alfano

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Isabella Laura Simone

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

L Lavorgna

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

S Bonavita

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

D Ippolito

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

F Patti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

P Valentino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

G Coniglio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

M Buccafusca

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

A d'Ambrosio

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

G Savettieri

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

M Zappia

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

A Gallo

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

G Tedeschi

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

9 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

220-226

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23838177%20AND%20SRC:MED&resulttype=core&format=json

The immunopathology of multiple sclerosis: an overview

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Natural history of multiple sclerosis: a unifying concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Natural history of multiple sclerosis: long-term prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Eight-year follow-up study of brain atrophy in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Brain atrophy and lesion load in a large population of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Patients' stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Measurement and clinical effect of grey matter pathology in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

T2 lesions and rate of progression of disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958

Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513494958